A calcium antagonistic effect of the new antiepileptic drug lamotrigine
Introduction
The new antiepileptic drug lamotrigine (LTG; 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine) has been shown to be effective in the treatment of focal epilepsies with or without secondary generalization (cf. Yuen, 1994). Furthermore, some case reports indicate an efficacy in the treatment of bipolar affective disorders (Weisler et al., 1994, Walden et al., 1996). It has been suggested that the main mechanism of action of LTG is the inhibition of glutamate release through blockade of voltage sensitive sodium channels and stabilisation of the neuronal membrane (Leach et al., 1986). Thus, LTG has been shown in voltage-clamp studies on rodent cells to inhibit voltage dependent sodium channels by tonic and use-dependent mechanisms (Lang and Wang, 1991). Moreover, LTG is able to induce a protection against striatal kainate neurotoxicity being dependent on the release of glutamate (McGeer and Zhu, 1990). This pharmacological profile resembles the action of phenytoin and carbamazepine both of which also exert depressive actions on sodium channels (cf. Catteral, 1987).
In the search for basic mechanisms in affective disorders a disturbed intracellular calcium ion homoeostasis is discussed (Dubovsky, 1993, Dubovsky et al., 1994, van Calker et al., 1993). Several clinical studies evaluated antimanic and partly also antidepressive actions of calcium antagonists like verapamil, diltiazem and nimodipine (cf. Brunet et al., 1990, Dubovsky, 1993, Walden et al., 1995). In this context it was found that the antiepileptic drug carbamazepine, which is used in the prophylaxis of affective and schizoaffective disorders, and also the antidepressant imipramine have other actions in addition to calcium antagonistic properties (Choi et al., 1992, Walden et al., 1992, Walden et al., 1993). Since in a recent study an effect of LTG on calcium channels in cultured cortical rat neurones was described (Lees and Leach, 1993), the aim of the present investigation was to test whether LTG may display also calcium antagonistic properties which may contribute to its pharmacological actions in men.
Section snippets
Materials and methods
The experiments were carried out in hippocampal slices of guinea pigs (300–400 μm thick). The brain was removed from the guinea pig under ether anesthesia. The slices were preincubated for 2 h in a 28°C standard saline solution containing (in mmol/l) NaCl 124, KCl 3, CaCl2 0.75, KH2PO4 1.24, MgCl2 1.3, NaHCO3 26 and glucose 10, which was equilibrated with 5% CO2 in O2 (carbogen). After preincubation the slices were transferred to a superfusion recording chamber which was continuously perfused
Results
During perfusion of the slice with a zero Mg2+ solution typical extracellular field potentials (EFP) developed spontaneously without any stimulation within a few minutes (cf. Fig. 1, CTRL-1) being the correlate of intracellularly recorded paroxysmal depolarization shifts (Mody et al., 1987; cf. Walden et al., 1992, Walden et al., 1993). Several investigations have shown that calcium currents essentially contribute to the generation of these EFP (cf. Pohl et al., 1992, Walden et al., 1992). The
Discussion
In the present study it was found that the new antiepileptic drug lamotrigine reduced dose-dependently the repetition rate of extracellular field potentials in the low-magnesium model of epilepsy. Furthermore, an addition of subthreshold concentrations of lamotrigine and the organic calcium antagonist verapamil or the antiepileptic drug carbamazepine, respectively, led also to a reduction of the frequency of occurrence of zero-Mg2+-induced field potentials. The zero-Mg2+ model is thought to
References (30)
- Bingmann, D. and Speckmann, E.-J. (1988) Specific suppression of pentylene-tetrazol-induced epileptiform discharges in...
- Brunet, G., Cerlich, B., Robert, P., Dumas, S., Souetre, E. and Darcourt, G. (1990) Open trial of a calcium antagonist,...
- Catteral, W.A. (1987) Common modes of drug action on Na+ channels: local anaesthetics, antiarrythmics and...
- Choi, J.J., Huang, G.-J., Shafik, E., Wu, W. and McArdle, J.J. (1992) Imipramine's selective suppression of an L-type...
- Dubovsky, S.L. (1993) Calcium antagonists in manic-depressive illness. Neuropsychobiology 27,...
- Dubovsky, S.L., Thomas, M., Hijazi, A., Murphy, J. (1994) Intracellular calcium signalling in peripheral cells of...
- Jones, R.S.G. and Heinemann, U. (1987) Differential effects of calcium channel blockers on pre- and postsynaptic influx...
- Lambert, J.D.C. and Heinemann, U. (1986) Aspects of the action of excitatory amino acids on hippocampal CA1 neurons....
- Lang, D.G. and Wang, C.M. (1991) Lamotrigine and phenytoin interactions on ionic channels present in N4TG1 and GH3...
- Leach, M.J., Marden, C.M. and Miller, A.A. (1986) Pharmacological studies on lamotrigine, a novel potential...
Cited by (63)
PLGA nanoparticles for nasal drug delivery
2024, Journal of Drug Delivery Science and TechnologyCommonly prescribed medications associated with alopecia
2023, Journal of the American Academy of DermatologyThe Epilepsies
2022, Comprehensive PharmacologyThe effect of fluoxetine on penicillin-induced epileptiform activity
2019, Epilepsy and BehaviorCitation Excerpt :It has been found that increased neuronal activity during epilepsy could be associated with voltage-gated Na + and Ca2 + channels [39,40]. Besides, conventional anticonvulsant drugs are known to inhibit voltage-dependent Na + and Ca2 + channels [41–45]. It was reported that the extracellular Ca2 + level increases before the onset of penicillin epilepsy in anesthetized cats, and it was found that penicillin could cause bursts by acting on parasynaptic routes and Ca2 + [46].
Current understanding of the mechanism of action of the antiepileptic drug lacosamide
2015, Epilepsy ResearchEfficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy
2009, European Journal of Paediatric NeurologyCitation Excerpt :Lamotrigine (LTG) was one of the first new antiepileptic drugs (AEDs) introduced in 1990 in Europe and in 1994 in USA. Its mechanisms of action include blockade of voltage-sensitive sodium channels to stabilize neuronal membranes, inhibition of the release of excitatory neurotransmitters, principally glutamate, and also blockade of calcium channels.42,40 LTG has been approved by the FDA in the US for use as adjunctive therapy in patients above 2 years of age for focal epilepsy or generalized epilepsy of the Lennox–Gastaut syndrome.